The U.S. International Trade Commission investigated a complaint from Heraeus Medical LLC and Heraeus Medical GmbH about misappropriation of trade secrets by companies including Zimmer Biomet Holdings, Inc. The investigation looked into whether these actions violated section 337, which concerns trade practices injuring U.S. industries. Ultimately, the Commission concluded that there was no violation as Heraeus failed to prove the existence of a domestic industry impacted by these actions. Thus, the investigation was terminated without penalties against Zimmer Biomet.
Simple Explanation
The U.S. International Trade Commission checked if some companies used secret ideas from another company without permission, but in the end, they decided that no rules were broken, so they stopped looking into it.